Simone Bido

About Simone Bido

Simone Bido, With an exceptional h-index of 16 and a recent h-index of 14 (since 2020), a distinguished researcher at Università Vita-Salute San Raffaele, specializes in the field of Parkinson's Disease, Dyskinesia, Mitochondrial dynamics, Inflammation, Microglia.

His recent articles reflect a diverse array of research interests and contributions to the field:

SETD5 haploinsufficiency affects mitochondrial compartment in neural cells

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden

A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development

Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome

Author Correction: Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

The mitochondrial targeted drug SBT-272 attenuates dopaminergic neuron loss, alpha-synuclein burden and neuroinflammation in a mouse model of Parkinson’s Disease

Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice

Simone Bido Information

University

Position

___

Citations(all)

1364

Citations(since 2020)

1032

Cited By

698

hIndex(all)

16

hIndex(since 2020)

14

i10Index(all)

18

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Simone Bido Skills & Research Interests

Parkinson's Disease

Dyskinesia

Mitochondrial dynamics

Inflammation

Microglia

Top articles of Simone Bido

SETD5 haploinsufficiency affects mitochondrial compartment in neural cells

Molecular autism

2023/6/1

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden

Blood, The Journal of the American Society of Hematology

2023/5/25

A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development

Science advances

2022/8/3

Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome

Nature communications

2022/1/10

Author Correction: Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

Nature Communications

2021

The mitochondrial targeted drug SBT-272 attenuates dopaminergic neuron loss, alpha-synuclein burden and neuroinflammation in a mouse model of Parkinson’s Disease

2021/9/1

Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

Nature communications

2021/10/29

dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice

Molecular Therapy

2020/1/8

Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease

Neurobiology of Disease

2020/6/1

See List of Professors in Simone Bido University(Università Vita-Salute San Raffaele)

Co-Authors

academic-engine